American Tungsten & Antimony (ASX:AT4): Why Has Quotation Been Suspended Over Del Sol?

Aditi Sarkar

28 October 2026 06:06 PM AEDT

American Tungsten & Antimony (ASX:AT4): Why Has Quotation Been Suspended Over Del Sol?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

American Tungsten & Antimony shares were suspended from ASX quotation on 28 October 2026.
The suspension followed the expiry of the company’s existing trading halt.
The company requested additional time to finalise a proposed transaction identified as Del Sol.
AT4 requested suspension until 30 October 2026, unless a relevant announcement allows an earlier end.
The suspension notice does not disclose transaction consideration, funding or completion conditions.

American Tungsten & Antimony Limited (ASX:AT4) is involved in the development of tungsten and antimony opportunities. On 28 October 2026, trading in its securities was suspended from quotation as the company worked to finalise a proposed Del Sol transaction. The announcement concerns the status of trading and the preparation of further information; it does not report a completed acquisition, binding transaction terms or new financial results. The distinction is central to interpreting what shareholders currently know.

Why the Existing Trading Halt Became a Suspension

The company requested suspension under ASX Listing Rule 17.2 after an existing trading halt expired. American Tungsten & Antimony (ASX:AT4) said it required more time to finalise the proposed Del Sol transaction and prepare an appropriate announcement to the market. The suspension is a procedural step intended to keep trading paused while material information remains under preparation.

The release dated 28 October 2026 followed an earlier trading halt announced on 26 October. A trading halt and a suspension both interrupt quotation, but the company’s latest notice makes clear that the earlier halt had reached its end without the expected transaction update being finalised.

What Is Known About the Del Sol Proposal?

American Tungsten & Antimony (ASX:AT4) identified Del Sol as the subject of the proposed transaction. However, the suspension request itself does not specify the transaction counterparties, assets being acquired or transferred, purchase consideration, funding arrangements or contractual conditions. It is therefore not possible to assess the proposed transaction’s financial size or its effect on the company from this release alone.

The absence of those details should not be mistaken for confirmation that negotiations have concluded. References to a proposed transaction do not establish that an agreement has been signed or completed. Any final commercial terms need to be assessed from a subsequent formal announcement, if released.

The Requested Timetable and Its Limits

American Tungsten & Antimony (ASX:AT4) requested that the suspension remain in place until trading resumes on Friday, 30 October 2026, unless an announcement about Del Sol is released earlier. This is the company’s requested timetable, not a guarantee of resumption. ASX may determine a different outcome, and the precise timing ultimately depends on the required disclosures and market arrangements.

The company also advised that it knew of no reason its suspension request should not be granted and no further information that needed disclosure in connection with that request. That statement relates to the suspension notice, not to undisclosed commercial terms.

What the Notice Means for Financial Assessment

The announcement provides no transaction price, revenue forecast, operating cost estimate, capital requirement or funding commitment. For American Tungsten & Antimony (ASX:AT4), the immediate development is therefore a quotation-status event rather than a measurable earnings or asset-value change. A numerical assessment of the proposed transaction would require details that have not yet been disclosed.

The suspension does not establish whether the eventual transaction would increase or decrease the company’s obligations. It also does not demonstrate that the proposal will proceed.

Key Insights

American Tungsten & Antimony (ASX:AT4) has confirmed a suspension following its expired trading halt while a proposed Del Sol announcement is finalised. The requested resumption date is 30 October 2026, subject to an earlier disclosure or an ASX decision. No binding transaction terms, costs or financial implications were provided. The next substantive milestone is the formal release explaining the proposal and any conditions attached to it.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.